Please login to the form below

Not currently logged in
Email:
Password:

job cuts

This page shows the latest job cuts news and features for those working in and with pharma, biotech and healthcare.

Pfizer drops neuroscience R&D, cutting 300 jobs

Pfizer drops neuroscience R&D, cutting 300 jobs

The job cuts will come mostly at its sites in Cambridge and Andover, Massachusetts, and in Groton, Connecticut, with about 100 losses expected at each.

Latest news

More from news
Approximately 45 fully matching, plus 89 partially matching documents found.

Latest Intelligence

  • Pharma deals during October 2013 Pharma deals during October 2013

    The month opened with the news that Merck &Co is eliminating a further 8, 500 jobs, in addition to the previously announced 7, 500 job cuts, in its plan to reduce

  • Partial privatisation shakes up pharma market in Spain Partial privatisation shakes up pharma market in Spain

    Pharma struggling with unpaid drug bills, price cuts and cost-containment measures amid upheaval of healthcare system. ... The reform is also expected to lead to significant job cuts (around 9, 000) in the public health sector, which will take place

  • Interview: Trevor Smith, Takeda Interview: Trevor Smith, Takeda

    Confronting mortality. Significant cuts may be on their way over the next four years, but Takeda and Nycomed have perhaps already come through the hardest parts of today's pharmaceutical environment.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics